Published since 1884 by the Society for the Study of Addiction
Editor-in-Chief, John Marsden
Nalmefene has long-term efficacy as alcohol reduction pharmacotherapy. Nalmefene and topiramate have higher frequency of adverse events than placebo.
Regular use of e-cigs or nicotine patches by pregnant smokers does not appear to be associated with any adverse outcomes.
There appears to be no association between MUP for alcohol in Scotland and the volume of alcohol-related ambulance callouts.
Maltreated children are three times more likely to develop substance use disorders in adulthood
18 April, 2024
The Irony of Smoking to Stay Thin: Smoking Increases Belly Fat
21 March, 2024
Want to quit smoking in 2024? Cytisine can help … if you live in the right country
1 January, 2024